Literature DB >> 18321617

Immunogenetic basis of HIV-1 infection, transmission and disease progression.

Paras Singh1, Gurvinder Kaur, Gaurav Sharma, Narinder K Mehra.   

Abstract

Susceptibility to HIV-1 infection and rate of disease progression to AIDS are complex traits modulated by environmental and genetic factors. Studies on large AIDS cohorts and their meta-analyses have identified numerous AIDS restriction genes that regulate HIV cell entry (particularly chemokine co-receptors and their ligands), acquired and innate immunity (major histocompatibility complex (MHC), killer immunoglobulin-like receptors (KIRs), and cytokines) and others that influence outcome of HIV infection. However, vast inter-individual variability is often observed and some rare individuals like 'long-term non-progressors (LTNPs) or exposed uninfected' (EUs) appear to be protected due to natural resistance. A better understanding of genetic basis of such a 'natural resistance' to infection would bear important implications in designing therapeutic vaccine designs. The genetic variants that could limit AIDS vary in different populations. We have studied genetic variations in the MHC, cytokines and CCR2-CCR5 loci in the Asian-Indian HIV-infected population and compared with other global populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321617     DOI: 10.1016/j.vaccine.2008.01.012

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  The Indian genetic landscape and disease-related genes.

Authors:  Evelyne Heyer
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

3.  Immunogenetic characterization of a captive colony of sooty mangabeys (Cercocebus atys) used for SIV research.

Authors:  Geary R Smith; Liesel Bauer; Maria M Crane; Zachary P Johnson
Journal:  J Med Primatol       Date:  2015-01-21       Impact factor: 0.667

4.  Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccine.

Authors:  Jagadish Chandrabose Sundaramurthi; Soumya Swaminathan; Luke Elizabeth Hanna
Journal:  Immunogenetics       Date:  2012-07-19       Impact factor: 2.846

5.  Molecular immune signatures of HIV-1 vaccines in human PBMCs.

Authors:  Alessandro Monaco; Francesco M Marincola; Marianna Sabatino; Zoltan Pos; Maria Lina Tornesello; David F Stroncek; Ena Wang; George K Lewis; Franco M Buonaguro; Luigi Buonaguro
Journal:  FEBS Lett       Date:  2009-08-06       Impact factor: 4.124

Review 6.  HIV Diagnosis and Treatment through Advanced Technologies.

Authors:  Hafiza Fizzah Zulfiqar; Aneeqa Javed; Bakht Afroze; Qurban Ali; Khadija Akbar; Tariq Nadeem; Muhammad Adeel Rana; Zaheer Ahmad Nazar; Idrees Ahmad Nasir; Tayyab Husnain
Journal:  Front Public Health       Date:  2017-03-07

7.  Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.

Authors:  Wildeman Zapata; Wbeimar Aguilar-Jiménez; Nicolás Pineda-Trujillo; Winston Rojas; Hernando Estrada; María T Rugeles
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-09       Impact factor: 2.205

8.  High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses.

Authors:  Juan F Arias; Reiko Nishihara; Manju Bala; Kazuyoshi Ikuta
Journal:  Retrovirology       Date:  2010-03-09       Impact factor: 4.602

9.  HIV infection and host genetic mutation among injecting drug-users of northeastern states of India.

Authors:  Kamalesh Sarkar; Santa Sabuj Das; Reshmi Pal; Baishali Bal; P Madhusudan; Sekhar Chakraborti
Journal:  J Health Popul Nutr       Date:  2010-04       Impact factor: 2.000

Review 10.  Human immunodeficiency virus vaccine trials.

Authors:  Robert J O'Connell; Jerome H Kim; Lawrence Corey; Nelson L Michael
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.